162 related articles for article (PubMed ID: 16154715)
1. Gene deregulation in gastric cancer.
Stock M; Otto F
Gene; 2005 Oct; 360(1):1-19. PubMed ID: 16154715
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-mesenchymal transition in gastric cancer (Review).
Katoh M
Int J Oncol; 2005 Dec; 27(6):1677-83. PubMed ID: 16273224
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of therapeutic approaches to gastric cancer.
Wu K; Nie Y; Guo C; Chen Y; Ding J; Fan D
J Gastroenterol Hepatol; 2009 Jan; 24(1):37-41. PubMed ID: 19196394
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis.
Vogiatzi P; Vindigni C; Roviello F; Renieri A; Giordano A
J Cell Physiol; 2007 May; 211(2):287-95. PubMed ID: 17238139
[TBL] [Abstract][Full Text] [Related]
5. Novel targets in gastric and esophageal cancer.
Valverde CM; Macarulla T; Casado E; Ramos FJ; Martinelli E; Tabernero J
Crit Rev Oncol Hematol; 2006 Aug; 59(2):128-38. PubMed ID: 16829119
[TBL] [Abstract][Full Text] [Related]
6. KCNE2, a down-regulated gene identified by in silico analysis, suppressed proliferation of gastric cancer cells.
Yanglin P; Lina Z; Zhiguo L; Na L; Haifeng J; Guoyun Z; Jie L; Jun W; Tao L; Li S; Taidong Q; Jianhong W; Daiming F
Cancer Lett; 2007 Feb; 246(1-2):129-38. PubMed ID: 16677757
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype.
Sanada Y; Oue N; Mitani Y; Yoshida K; Nakayama H; Yasui W
J Pathol; 2006 Apr; 208(5):633-42. PubMed ID: 16435283
[TBL] [Abstract][Full Text] [Related]
8. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells.
Chen YR; Juan HF; Huang HC; Huang HH; Lee YJ; Liao MY; Tseng CW; Lin LL; Chen JY; Wang MJ; Chen JH; Chen YJ
J Proteome Res; 2006 Oct; 5(10):2727-42. PubMed ID: 17022644
[TBL] [Abstract][Full Text] [Related]
9. ZIC1 is downregulated through promoter hypermethylation in gastric cancer.
Wang LJ; Jin HC; Wang X; Lam EK; Zhang JB; Liu X; Chan FK; Si JM; Sung JJ
Biochem Biophys Res Commun; 2009 Feb; 379(4):959-63. PubMed ID: 19135984
[TBL] [Abstract][Full Text] [Related]
10. A small interfering RNA targeting osteopontin as gastric cancer therapeutics.
Gong M; Lu Z; Fang G; Bi J; Xue X
Cancer Lett; 2008 Dec; 272(1):148-59. PubMed ID: 18694621
[TBL] [Abstract][Full Text] [Related]
11. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
[TBL] [Abstract][Full Text] [Related]
12. Pathology and molecular biology of gastric cancer.
Vauhkonen M; Vauhkonen H; Sipponen P
Best Pract Res Clin Gastroenterol; 2006; 20(4):651-74. PubMed ID: 16997151
[TBL] [Abstract][Full Text] [Related]
13. How do we improve outcomes for gastric cancer?
Yeoh KG
J Gastroenterol Hepatol; 2007 Jul; 22(7):970-2. PubMed ID: 17524038
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
[TBL] [Abstract][Full Text] [Related]
15. Gene expression analysis of early and advanced gastric cancers.
Vecchi M; Nuciforo P; Romagnoli S; Confalonieri S; Pellegrini C; Serio G; Quarto M; Capra M; Roviaro GC; Contessini Avesani E; Corsi C; Coggi G; Di Fiore PP; Bosari S
Oncogene; 2007 Jun; 26(29):4284-94. PubMed ID: 17297478
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic and molecular aspects of gastric cancer: clinical implications.
Panani AD
Cancer Lett; 2008 Aug; 266(2):99-115. PubMed ID: 18381231
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of response to therapy in oesophago-gastric cancer.
Fareed KR; Kaye P; Soomro IN; Ilyas M; Martin S; Parsons SL; Madhusudan S
Gut; 2009 Jan; 58(1):127-43. PubMed ID: 19091831
[TBL] [Abstract][Full Text] [Related]
18. [Study on gene expression profile difference in gastric cancer, pericancerous mucosa and normal gastric mucosa from the distant cutting margin by oligonucleotide microarray].
Yu CD; Xu SH; Mou HZ; Jiang ZM; Zhu CH; Liu XL
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Nov; 8(6):520-3. PubMed ID: 16299656
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of hepatocellular carcinoma.
Aravalli RN; Steer CJ; Cressman EN
Hepatology; 2008 Dec; 48(6):2047-63. PubMed ID: 19003900
[TBL] [Abstract][Full Text] [Related]
20. Hath1 up-regulates gastric mucin gene expression in gastric cells.
Sekine A; Akiyama Y; Yanagihara K; Yuasa Y
Biochem Biophys Res Commun; 2006 Jun; 344(4):1166-71. PubMed ID: 16647036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
